CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 60 enrolled
Drug / intervention
Resveratrol +2 moredrug
Likely dose
Resveratrol 250 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02523274
NCT02523274Phase 2Completed
CompareCT.gov

Resveratrol and Exercise to Treat Functional Limitations in Late Life

University of Florida·interventional·Posted Aug 14, 2015·Updated Jan 13, 2022

In Brief

A Phase 2 clinical trial evaluating Resveratrol, Placebo, and 1 other intervention for Aging. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The purpose of this research study is to evaluate the effects of combining physical exercise with a resveratrol supplementation on the physical function of older adults.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAging
CountriesUnited States
CollaboratorsNational Institute on Aging (NIA), University of Alabama at Birmingham

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 14, 2015
Enrollment StartJun 1, 2016
Primary CompletionMay 1, 2019
Study CompletionJul 17, 2019
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 10.9 years ago

Interventions

Resveratroldrug

Dietary compound commonly found in grapes and red wine. Will be given in 250 mg/day and 1000 mg/day dosages

Placebodrug

Vegetable-based cellulose

Exercisebehavioral

Multi-modal exercise regimen, 3 days/week